Brief: Ac Immune Partner LMI Progresses Tau PET Tracer PI-2620 Into Late-Stage Development In Alzheimer’S Disease
26/09/2022 14:15
Sept 26 (Reuters) - AC Immune SA ACIU.O :
* AC IMMUNE PARTNER LMI PROGRESSES TAU PET TRACER PI-2620
INTO
LATE-STAGE DEVELOPMENT IN ALZHEIMER’S DISEASE
* AC IMMUNE SA - AS PART OF AGREEMENT WITH AC IMMUNE, LMI
WILL
MAKE A MILESTONE PAYMENT.
Source text for Eikon: ID:nGNXbCTxMf
Further company coverage: ACIU.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on AC Immune SA
See all newsBrief: Ac Immune To Receive Research Grant From Goradia Family For Development Of Aci-7104 In Parkinson’S Disease
AC Immune Q1 net loss narrows on lower expenses
Brief: AC Immune Announces Amendment To Morphomer ® Tau License And Collaboration Agreement With Lilly
U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture
U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture